Prof.Dr.med. ID: 6488383
Katja Weisel
Publications
Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication
Gammaitoni, L., Weisel, K. C., Gunetti, M., Wu, K-D., Bruno, S., Pinelli, S., Bonati, A., Aglietta, M., Moore, M. A. S. & Piacibello, W., 15.06.2004, In: BLOOD. 103, 12, p. 4440-8 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study
Dimopoulos, M. A., Lonial, S., White, D., Moreau, P., Weisel, K., San-Miguel, J., Shpilberg, O., Grosicki, S., Špička, I., Walter-Croneck, A., Magen, H., Mateos, M-V., Belch, A., Reece, D., Beksac, M., Spencer, A., Oakervee, H., Orlowski, R. Z., Taniwaki, M., Röllig, C., Einsele, H., Matsumoto, M., Wu, K. L., Anderson, K. C., Jou, Y-M., Ganetsky, A., Singhal, A. K. & Richardson, P. G., 04.09.2020, In: BLOOD CANCER J. 10, 9, p. 91Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial
Mai, E. K., Goldschmid, H., Miah, K., Bertsch, U., Besemer, B., Hänel, M., Krzykalla, J., Fenk, R., Schlenzka, J., Munder, M., Dürig, J., Blau, I. W., Huhn, S., Hose, D., Jauch, A., Kunz, C., Mann, C., Weinhold, N., Scheid, C., Schroers, R., von Metzler, I., Schieferdecker, A., Thomalla, J., Reimer, P., Mahlberg, R., Graeven, U., Kremers, S., Martens, U. M., Kunz, C., Hensel, M., Benner, A., Seidel-Glätzer, A., Weisel, K. C., Raab, M. S., Salwender, H. J. & German-speaking Myeloma Multicenter Group (GMMG) HD6 investigators, 02.2024, In: LANCET HAEMATOL. 11, 2, p. e101-e113Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 4-year follow-up and analysis of relative progression-free survival from the randomized ELOQUENT-2 trial
Dimopoulos, M. A., Lonial, S., Betts, K. A., Chen, C., Zichlin, M. L., Brun, A., Signorovitch, J. E., Makenbaeva, D., Mekan, S., Sy, O., Weisel, K. & Richardson, P. G., 15.10.2018, In: CANCER-AM CANCER SOC. 124, 20, p. 4032-4043 12 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma
Weisel, K. C., Weidmann, E., Anagnostopoulos, I., Kanz, L., Pezzutto, A. & Subklewe, M., 11.2008, In: International journal of hematology. 88, 4, p. 434-440 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): a randomised control trial
Hutchison, C. A., Cook, M., Heyne, N., Weisel, K., Billingham, L., Bradwell, A. & Cockwell, P., 28.09.2008, In: TRIALS. 9, p. 55Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy
Chari, A., Munder, M., Weisel, K., Jenner, M., Bygrave, C., Petrucci, M. T., Boccadoro, M., Cavo, M., van de Donk, N. W. C. J., Turgut, M., Demirkan, F., Karadogan, I., Libby, E., Kleiman, R., Kuppens, S., Bandekar, R., Neff, T., Heuck, C., Qi, M., Clemens, P. L. & Goldschmidt, H., 02.2021, In: ADV THER. 38, 2, p. 1328-1341 14 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR
Avet-Loiseau, H., San-Miguel, J., Casneuf, T., Iida, S., Lonial, S., Usmani, S. Z., Spencer, A., Moreau, P., Plesner, T., Weisel, K., Ukropec, J., Chiu, C., Trivedi, S., Amin, H., Krevvata, M., Ramaswami, P., Qin, X., Qi, M., Sun, S., Qi, M., Kobos, R. & Bahlis, N. J., 01.04.2021, In: J CLIN ONCOL. 39, 10, p. 1139-1149 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma
Dimopoulos, M. A., Leleu, X., Palumbo, A., Moreau, P., Delforge, M., Cavo, M., Ludwig, H., Morgan, G. J., Davies, F. E., Sonneveld, P., Schey, S. A., Zweegman, S., Hansson, M., Weisel, K., Mateos, M. V., Facon, T. & Miguel, J. F. S., 08.2014, In: LEUKEMIA. 28, 8, p. 1573-85 13 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Extended in vitro expansion of adult, mobilized CD34+ cells without significant cell senescence using a stromal cell coculture system with single cytokine support
Weisel, K. C., Moore, M. A. S., Kanz, L. & Möhle, R., 03.2009, In: STEM CELLS DEV. 18, 2, p. 229-34 6 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Extracorporeal light chain elimination: high cut-off (HCO) hemodialysis parallel to chemotherapy allows for a high proportion of renal recovery in multiple myeloma patients with dialysis-dependent acute kidney injury
Heyne, N., Denecke, B., Guthoff, M., Oehrlein, K., Kanz, L., Häring, H-U. & Weisel, K. C., 05.2012, In: ANN HEMATOL. 91, 5, p. 729-735 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study
Usmani, S. Z., Quach, H., Mateos, M-V., Landgren, O., Leleu, X., Siegel, D. S., Weisel, K. C., Shu, X., Li, C. & Dimopoulos, M. A., 25.07.2023, In: BLOOD ADV. 7, 14, p. 3739-3748 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma
Facon, T., Dimopoulos, M. A., Dispenzieri, A., Catalano, J. V., Belch, A., Cavo, M., Pinto, A., Weisel, K., Ludwig, H., Bahlis, N. J., Banos, A., Tiab, M., Delforge, M., Cavenagh, J. D., Geraldes, C., Lee, J-J., Chen, C., Oriol, A., De La Rubia, J., White, D., Binder, D., Lu, J., Anderson, K. C., Moreau, P., Attal, M., Perrot, A., Arnulf, B., Qiu, L., Roussel, M., Boyle, E., Manier, S., Mohty, M., Avet-Loiseau, H., Leleu, X., Ervin-Haynes, A., Chen, G., Houck, V., Benboubker, L. & Hulin, C., 18.01.2018, In: BLOOD. 131, 3, p. 301-310 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
First-in-Human Phase I Study of ABBV-838, an Antibody-Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma
Vij, R., Nath, R., Afar, D. E. H., Mateos, M. V., Berdeja, J. G., Raab, M. S., Guenther, A., Martinez-Lopez, J., Jakubowiak, A. J., Leleu, X., Weisel, K., Wong, S., Gulbranson, S., Sheridan, J. P., Reddy, A., Paiva, B., Singhal, A., San-Miguel, J. F. & Moreau, P., 15.05.2020, In: CLIN CANCER RES. 26, 10, p. 2308-2317 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Follow-up of patients with refractory or relapsed multiple myeloma after allogeneic hematopoietic cell transplantation
Schneidawind, C., Duerr-Stoerzer, S., Faul, C., Kanz, L., Weisel, K., Bethge, W. & Schneidawind, D., 07.2017, In: CLIN TRANSPLANT. 31, 7Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Frequency of expression and generation of T-cell responses against antigens on multiple myeloma cells in patients included in the GMMG-MM5 trial
Schmitt, M., Hückelhoven, A. G., Hundemer, M., Schmitt, A., Lipp, S., Emde, M., Salwender, H., Hänel, M., Weisel, K., Bertsch, U., Dürig, J., Ho, A. D., Blau, I. W., Goldschmidt, H., Seckinger, A. & Hose, D., 17.10.2017, In: ONCOTARGET. 8, 49, p. 84847-84862 16 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma: matching-adjusted indirect comparison
Moreau, P., Hebraud, B., Facon, T., Leleu, X., Hulin, C., Hashim, M., Hu, Y., Caillot, D., Benboubker, L., Zweegman, S., Merz, M., Weisel, K., Salwender, H., Mai, E. K., Goldschmidt, H., Bertsch, U., Vanquickelberghe, V., Kampfenkel, T., Boer, C. D., Krotneva, S., Proskorovsky, I., He, J., Lam, A., Lee, C., Cote, S. & Sonneveld, P., 02.2021, In: IMMUNOTHERAPY-UK. 13, 2, p. 143-154 12 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Genetic and functional characterization of isolated stromal cell lines from the aorta-gonado-mesonephros region
Weisel, K. C. & Moore, M. A. S., 06.2005, In: ANN NY ACAD SCI. 1044, p. 51-9 9 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Genomic Classification and Individualized Prognosis in Multiple Myeloma
Maura, F., Rajanna, A. R., Ziccheddu, B., Poos, A. M., Derkach, A., Maclachlan, K., Durante, M., Diamond, B., Papadimitriou, M., Davies, F., Boyle, E. M., Walker, B., Hultcrantz, M., Silva, A., Hampton, O., Teer, J. K., Siegel, E. M., Bolli, N., Jackson, G. H., Kaiser, M., Pawlyn, C., Cook, G., Kazandjian, D., Stein, C., Chesi, M., Bergsagel, L., Mai, E. K., Goldschmidt, H., Weisel, K. C., Fenk, R., Raab, M. S., Van Rhee, F., Usmani, S., Shain, K. H., Weinhold, N., Morgan, G. & Landgren, O., 10.04.2024, In: J CLIN ONCOL. 42, 11, p. 1229-1240 12 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials
Laane, E., Salek, S., Oliva, E. N., Bennink, C., Clavreul, S., Richardson, P. G., Scheid, C., Weisel, K., Ionova, T. & European Hematology Association Specialized Working Group on Quality of Life and Symptoms, 08.12.2023, In: CANCERS. 15, 24, 5764.Research output: SCORING: Contribution to journal › Guideline, recommendation, statement › Research › peer-review
Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma Cells
Hambach, J., Fumey, W., Stähler, T., Gebhardt, A. J., Adam, G., Weisel, K., Koch-Nolte, F. & Bannas, P., 2022, In: FRONT IMMUNOL. 13, 838406.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Hämophagozytische Lymphohistiozytose und Makrophagenaktivierungssyndrom: Eine multidisziplinäre Herausforderung
Ruffer, N., Kosch, R., Weisel, K., Kötter, I. & Krusche, M., 06.2024, In: Z RHEUMATOL. 83, 5, p. 376-386 11 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma
Song, K. W., Dimopoulos, M. A., Weisel, K. C., Moreau, P., Palumbo, A., Belch, A., Schey, S., Sonneveld, P., Sternas, L., Yu, X., Amatya, R., Monzini, M. S., Zaki, M., Jacques, C. & San Miguel, J., 02.2015, In: HAEMATOLOGICA. 100, 2, p. e63-7Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Health-related quality of life in the ENDEAVOR study: carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myeloma
Ludwig, H., Moreau, P., Dimopoulos, M. A., Mateos, M-V., Kaiser, M., Hajek, R., Feng, S., Cocks, K., Buchanan, J. & Weisel, K., 22.02.2019, In: BLOOD CANCER J. 9, 3, p. 23Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial
Perrot, A., Facon, T., Plesner, T., Usmani, S. Z., Kumar, S., Bahlis, N. J., Hulin, C., Orlowski, R. Z., Nahi, H., Mollee, P., Ramasamy, K., Roussel, M., Jaccard, A., Delforge, M., Karlin, L., Arnulf, B., Chari, A., He, J., Ho, K. F., Van Rampelbergh, R., Uhlar, C. M., Wang, J., Kobos, R., Gries, K. S., Fastenau, J. & Weisel, K., 20.01.2021, In: J CLIN ONCOL. 39, 3, p. 227-237 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Health-related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial
Hungria, V., Beksac, M., Weisel, K. C., Nooka, A. K., Masszi, T., Spicka, I., Munder, M., Mateos, M-V., Mark, T. M., Qi, M., Qin, X., Fastenau, J., Spencer, A., Sonneveld, P., Garvin, W., Renaud, T. & Gries, K. S., 05.2021, In: BRIT J HAEMATOL. 193, 3, p. 561-569 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Health-related quality of life of carfilzomib- and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma, based on German benefit assessment data
Weisel, K., Ludwig, H., Rieth, A., Lebioda, A. & Goldschmidt, H., 01.2020, In: QUAL LIFE RES. 29, 1, p. 69-79 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Health-related quality of life outcomes from the CANDOR study in patients with relapsed or refractory multiple myeloma
Siegel, D., Weisel, K., Zahlten-Kumeli, A., Medhekar, R., Ding, B. & Leleu, X., 12.2021, In: LEUKEMIA LYMPHOMA. 62, 12, p. 3002-3010 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma
Weisel, K., Dimopoulos, M., Moreau, P., Yagci, M., Larocca, A., Kanate, A. S., Vural, F., Cascavilla, N., Basu, S., Johnson, P., Byeff, P., Hus, M., Rodríguez-Otero, P., Muelduer, E., Anttila, P., Hayden, P. J., Krauth, M-T., Lucio, P., Ben-Yehuda, D., Mendeleeva, L., Guo, S., Yu, X., Grote, L., Biyukov, T., Dhanasiri, S. & Richardson, P., 08.2020, In: LEUKEMIA LYMPHOMA. 61, 8, p. 1850-1859 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial
Hutchison, C. A., Cockwell, P., Moroz, V., Bradwell, A. R., Fifer, L., Gillmore, J. D., Jesky, M. D., Storr, M., Wessels, J., Winearls, C. G., Weisel, K., Heyne, N. & Cook, M., 04.2019, In: LANCET HAEMATOL. 6, 4, p. e217-e228Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial
Lonial, S., Popat, R., Hulin, C., Jagannath, S., Oriol, A., Richardson, P. G., Facon, T., Weisel, K., Larsen, J. T., Minnema, M. C., Abdallah, A-O., Badros, A. Z., Knop, S., Stadtmauer, E. A., Cheng, Y., Amatangelo, M., Chen, M., Nguyen, T. V., Amin, A., Peluso, T. & van de Donk, N. W. C. J., 11.2022, In: LANCET HAEMATOL. 9, 11, p. e822-e832Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Munshi, N. C., Anderson, L. D., Shah, N., Madduri, D., Berdeja, J., Lonial, S., Raje, N., Lin, Y., Siegel, D., Oriol, A., Moreau, P., Yakoub-Agha, I., Delforge, M., Cavo, M., Einsele, H., Goldschmidt, H., Weisel, K., Rambaldi, A., Reece, D., Petrocca, F., Massaro, M., Connarn, J. N., Kaiser, S., Patel, P., Huang, L., Campbell, T. B., Hege, K. & San-Miguel, J., 25.02.2021, In: NEW ENGL J MED. 384, 8, p. 705-716 12 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage Display
Krohn, S., Boje, A. S., Gehlert, C. L., Lutz, S., Darzentas, N., Knecht, H., Herrmann, D., Brüggemann, M., Scheidig, A. J., Weisel, K., Gramatzki, M., Peipp, M. & Klausz, K., 2022, In: FRONT IMMUNOL. 13, 908093.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Imaging findings in relapsing multiple myeloma
Sauter, A., Weisel, K. & Horger, M., 08.2010, In: BRIT J HAEMATOL. 150, 4, p. 388Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma: Final Data From the Phase 2 ELOQUENT-3 Trial
Weisel, K., Dimopoulos, M. A., San-Miguel, J., Paner, A., Engelhardt, M., Taylor, F., Lord-Bessen, J., Yip, C., Greenwood, M., Tang, J. & Cavo, M., 03.2023, In: HEMASPHERE. 7, 3, p. e843Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma
San Miguel, J. F., Weisel, K. C., Song, K. W., Delforge, M., Karlin, L., Goldschmidt, H., Moreau, P., Banos, A., Oriol, A., Garderet, L., Cavo, M., Ivanova, V., Alegre, A., Martinez-Lopez, J., Chen, C., Renner, C., Bahlis, N. J., Yu, X., Teasdale, T., Sternas, L., Jacques, C., Zaki, M. H. & Dimopoulos, M. A., 10.2015, In: HAEMATOLOGICA. 100, 10, p. 1334-9 6 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study
Moreau, P., Joshua, D., Chng, W-J., Palumbo, A., Goldschmidt, H., Hájek, R., Facon, T., Ludwig, H., Pour, L., Niesvizky, R., Oriol, A., Rosiñol, L., Suvorov, A., Gaidano, G., Pika, T., Weisel, K., Goranova-Marinova, V., Gillenwater, H. H., Mohamed, N., Aggarwal, S., Feng, S. & Dimopoulos, M. A., 01.2017, In: LEUKEMIA. 31, 1, p. 115-122 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma
Mai, E. K., Huhn, S., Miah, K., Poos, A. M., Scheid, C., Weisel, K. C., Bertsch, U., Munder, M., Berlanga, O., Hose, D., Seckinger, A., Jauch, A., Blau, I. W., Hänel, M., Salwender, H. J., Benner, A., Raab, M. S., Goldschmidt, H. & Weinhold, N., 04.01.2023, In: BLOOD CANCER J. 13, 1, p. 1Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg: Report of the University Cancer Center Hamburg
Weisel, K. C., Morgner-Miehlke, A., Petersen, C., Fiedler, W., Block, A., Schafhausen, P., Knobloch, J. K. & Bokemeyer, C., 07.05.2020, In: ONCOL RES TREAT. 43, 6, p. 307-313 7 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Improved Follow-Up and Response Monitoring of Thoracic Cage Involvement in Multiple Myeloma Using a Novel CT Postprocessing Software: The Lessons We Learned
Bier, G., Mustafa, D. F., Kloth, C., Weisel, K., Ditt, H., Nikolaou, K. & Horger, M., 01.2016, In: AM J ROENTGENOL. 206, 1, p. 57-63 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Improved MDCT monitoring of pelvic myeloma bone disease through the use of a novel longitudinal bone subtraction post-processing algorithm
Horger, M., Thaiss, W. M., Ditt, H., Weisel, K., Fritz, J., Nikolaou, K., Liao, S. & Kloth, C., 07.2017, In: EUR RADIOL. 27, 7, p. 2969-2977 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Improvement of diagnostic confidence for detection of multiple myeloma involvement of the ribs by a new CT software generating rib unfolded images: Comparison with 5- and 1-mm axial images
Homann, G., Weisel, K., Mustafa, D. F., Ditt, H., Nikolaou, K. & Horger, M., 07.2015, In: SKELETAL RADIOL. 44, 7, p. 971-9 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Improving outcomes for patients with relapsed multiple myeloma: Challenges and considerations of current and emerging treatment options
Ramasamy, K., Gay, F., Weisel, K., Zweegman, S., Mateos, M. V. & Richardson, P., 09.2021, In: Blood reviews. 49, p. 100808Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Increased incidence of immune thrombocytopenia (ITP) in 2021 correlating with the ongoing vaccination campaign against COVID-19 in a tertiary center - A monocentric analysis
Schaefers, C., Paulsen, F-O., Frenzel, C., Weisel, K., Bokemeyer, C. & Seidel, C., 04.2023, In: BRIT J HAEMATOL. 201, 2, p. 222-226 5 p.Research output: SCORING: Contribution to journal › Short publication › Research › peer-review
Increasing bone sclerosis during bortezomib therapy in multiple myeloma patients: results of a reduced-dose whole-body MDCT study
Schulze, M., Weisel, K., Grandjean, C., Oehrlein, K., Zago, M., Spira, D. & Horger, M., 01.2014, In: AM J ROENTGENOL. 202, 1, p. 170-9 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma
Costello, C., Davies, F. E., Cook, G., Vela-Ojeda, J., Omel, J., Rifkin, R. M., Berdeja, J., Puig, N., Usmani, S. Z., Weisel, K., Zonder, J. A., Terpos, E., Spencer, A., Leleu, X., Boccadoro, M., Thompson, M. A., Romanus, D., Stull, D. M. & Hungria, V., 05.2019, In: FUTURE ONCOL. 15, 13, p. 1411-1428 18 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials
Gavriatopoulou, M., Chari, A., Chen, C., Bahlis, N., Vogl, D. T., Jakubowiak, A., Dingli, D., Cornell, R. F., Hofmeister, C. C., Siegel, D., Berdeja, J. G., Reece, D., White, D., Lentzsch, S., Gasparetto, C., Huff, C. A., Jagannath, S., Baz, R., Nooka, A. K., Richter, J., Abonour, R., Parker, T. L., Yee, A. J., Moreau, P., Lonial, S., Tuchman, S., Weisel, K. C., Mohty, M., Choquet, S., Unger, T. J., Li, K., Chai, Y., Li, L., Shah, J., Shacham, S., Kauffman, M. G. & Dimopoulos, M. A., 09.2020, In: LEUKEMIA. 34, 9, p. 2430-2440 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis
Karagiannis, P., Sänger, L., Alsdorf, W., Weisel, K., Fiedler, W., Kluge, S., Wichmann, D., Bokemeyer, C. & Fuhrmann, V., 24.06.2020, In: CANCERS. 12, 6, 1678.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
Rodriguez-Otero, P., Usmani, S., Cohen, A. D., van de Donk, N. W. C. J., Leleu, X., Pérez-Larraya, J. G., Manier, S., Nooka, A. K., Mateos, M. V., Einsele, H., Minnema, M., Cavo, M., Derman, B. A., Puig, N., Gay, F., Ho, P. J., Chng, W-J., Kastritis, E., Gahrton, G., Weisel, K., Nagarajan, C., Schjesvold, F., Mikhael, J., Costa, L., Raje, N. S., Zamagni, E., Hájek, R., Weinhold, N., Yong, K., Ye, J. C., Sidhana, S., Merlini, G., Martin, T., Lin, Y., Chari, A., Popat, R., Kaufman, J. L. & International Myeloma Working Group, 05.2024, In: LANCET ONCOL. 25, 5, p. e205-e216Research output: SCORING: Contribution to journal › SCORING: Review article › Research
International Symposium and Workshop on hematopoietic stem cells VII, University of Tübingen, Germany, September 18-20, 2008
Weisel, K. C., Dick, J., Fibbe, W. E. & Kanz, L., 09.2009, In: ANN NY ACAD SCI. 1176, p. 1-17 17 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review